pemoline

(redirected from Cylert)
Also found in: Medical.

pemoline

(ˈpɛməˌliːn)
n
(Pharmacology) a stimulant used to treat fatigue, narcolepsy, and similar conditions
References in periodicals archive ?
Following a number of high-profile cases, such as the 2010 recall of Cylert, a central nervous system stimulant to treat ADHD/ADD, and the 2011 recall of Xigris, a treatment for severe sepsis and septic shock that was found to give patients no survival benefit, there is increased pressure to guarantee that pharmaceutical formulations are safe to use.
Cylert, Provigil) have become commonplace and readily available to high school and college students who are not diagnosed with AD/ HD (Advokat, Lane, & Luo, 2010).
Among his cataloguing, he remembers "[r]italin versus Ritadex, Cylert and Obetrol, Laverne and Shirley, Carnation Instant Breakfast, John Travolta, disco fever, and children's tee shirts with 'Fonz' on them.
Pemoline, known by its trade name, Cylert, is a prescription medication that was once used for MS-related fatigue.
The most common treatment, drug therapy, consists of stimulant medications such as Ritalin (methylphenidate), Dexedrine (dextroamphetamine), and Cylert (pemoline) (Greydanus, 2005; Olfson, 2004).
Despite extensive investigations by the British Horseracing Authority, the failure to find the source of the drug, pemoline, which has the trade name Cylert, has left Bowen a worried man.
Drugs that have been associated with unintentional weight loss include selective serotonin reuptake inhibitors such as Paxil, Prozac, and Celexa; cardiac agents such as Lasix, Lanoxin, and Vascor; amphetamines; appetite suppressants such as Adderall, Dexedrine, Cylert, Meridia, and Ritalin; and benzodiazepines such as Ativan and Klonopin.
Abbott Laboratories, which marketed Cylert, and the companies that manufacture generic pemoline have all agreed to stop sales and marketing of this drug.
Abbott Laboratories, which marketed Cylert, and the companies that manufacture generic pemoline have all agreed to stop sales and marketing of this drug, which is a central nervous system stimulant used in the treatment of attention-deficit hyperactivity disorder (ADHD).
Abbott Laboratories, which marketed Cylert, and the companies that manufacture genetic pemoline have all agreed to stop sales and marketing of this drug, which is a central nervous system stimulant used in the treatment of attention-deficit hyperactivity disorder (ADHD).
Adderall, Concerta, Ritalin, Cylert, and Dexedrine) and how they could potentially affect her behavior, academic performance, and social functioning could help to enhance client well-being (Hall & Gushee, 2002).